Accessibility Menu
 
Hypera logo

Hypera

(OTC) HYPMY

Current Price$4.34
Market Cap$3.12B
Since IPO (2010)-58%
5 Year-6%
1 Year+33%
1 Month+1%

Hypera Financials at a Glance

Market Cap

$3.12B

Revenue (TTM)

$7.70B

Net Income (TTM)

$1.20B

EPS (TTM)

$0.34

P/E Ratio

12.94

Dividend

$0.21

Beta (Volatility)

0.46 (Low)

Price

$4.34

Volume

1,564

Open

$4.41

Previous Close

$4.43

Daily Range

$4.34 - $4.41

52-Week Range

$3.17 - $5.50

HYPMY News

HYPMY: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hypera

Industry

Pharmaceuticals

Employees

10,564

CEO

Breno Toledo Pires de Oliveira, MBA

Headquarters

São Paulo, SP 05676-120, BR

HYPMY Financials

Key Financial Metrics (TTM)

Gross Margin

58%

Operating Margin

23%

Net Income Margin

16%

Return on Equity

10%

Return on Capital

7%

Return on Assets

4%

Earnings Yield

7.73%

Dividend Yield

0.05%

Payout Ratio

52.52%

Stock Overview

Market Cap

$3.12B

Shares Outstanding

703.53M

Volume

1.56K

Short Interest

0.00%

Avg. Volume

19.78K

Financials (TTM)

Gross Profit

$4.55B

Operating Income

$1.74B

EBITDA

$2.26B

Operating Cash Flow

$2.57B

Capital Expenditure

$799.36M

Free Cash Flow

$1.78B

Cash & ST Invst.

$1.65B

Total Debt

$9.34B

Hypera Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$2.24B

+48.1%

Gross Profit

$1.43B

+81.5%

Gross Margin

63.82%

N/A

Market Cap

$3.12B

N/A

Market Cap/Employee

$297.36K

N/A

Employees

10,481

N/A

Net Income

$450.99M

+466.9%

EBITDA

$790.03M

+456.7%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$7.69B

-0.4%

Accounts Receivable

$1.69B

-24.8%

Inventory

$2.08B

+7.3%

Long Term Debt

$8.01B

+0.2%

Short Term Debt

$1.33B

-5.6%

Return on Assets

4.18%

N/A

Return on Invested Capital

7.09%

N/A

Free Cash Flow

$519.66M

+19.8%

Operating Cash Flow

$708.12M

+1.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VRBCFVirbac S.A.
$384.75+0.00%
SHWGFShandong Weigao Group Medical Polymer Company Limited
$0.73+0.00%
APNHYAspen Pharmacare Holdings Limited
$7.63+2.01%
ULIHFThe United Laboratories International Holdings Limited
$1.33+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.95-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.27+0.04%
ARTLArtelo Biosciences
$12.75+3.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.52-0.06%

Questions About HYPMY

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.